Stay updated on Pembrolizumab Combo in Gastro Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Gastro Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedClinicalTrials.gov’s page footer/update label changed from revision **v3.5.0** to **v3.5.3**, reflecting a site/version update without changing the study record content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe page shows revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check82 days agoChange DetectedThe update adds a related topic 'Gastric cancer' and an external resource link to the Genetic and Rare Diseases Information Center, plus a page revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, indicating a site version update. This update does not modify the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Gastro Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.